GSK plc (GSK)

38.63 -0.19 (-0.49%) At close: 04:00PM EDT

GSK plc

980 Great West Road
Middlesex
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sector(s): Healthcare
Industry: Drug Manufacturers - General
Full-time employees: 70,212

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Emma Natasha Walmsley	CEO & Director	7.14M	71.47M	1969
Ms. Julie Belita Brown	CFO & Executive Director	6.82M	N/A	1962
Ms. Shobie Ramakrishnan	Chief Digital & Technology Officer	N/A	N/A	1971
Mr. Tony Wood	Chief Scientific Officer and Head of R&D	N/A	N/A	N/A
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A
Mr. James Ford	Senior VP & Group General Counsel of Legal & Compliance	N/A	N/A	N/A
Ms. Sally Jackson	Senior Vice President of Global Communications & CEO Office	N/A	N/A	N/A
Mr. David Simon Redfern BSc (Hons), CA	President of Corporate Development	N/A	N/A	1966
Ms. Diana Conrad	Chief People Officer	N/A	N/A	N/A
Mr. Philip C. Thomson	President of Global Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development, as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate governance

GSK plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.